Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$4.74.

  • bioAffinity Technologies' EPS (Weighted Average and Diluted) rose 206.61% to -$4.74 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4, marking a year-over-year increase of 28943.53%. This contributed to the annual value of -$0.75 for FY2024, which is 1807.13% up from last year.
  • bioAffinity Technologies' EPS (Weighted Average and Diluted) amounted to -$4.74 in Q3 2025, which was up 206.61% from -$0.17 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' EPS (Weighted Average and Diluted) ranged from a high of $0.22 in Q4 2022 and a low of -$4.84 during Q3 2024
  • For the 4-year period, bioAffinity Technologies' EPS (Weighted Average and Diluted) averaged around -$0.89, with its median value being -$0.2 (2023).
  • As far as peak fluctuations go, bioAffinity Technologies' EPS (Weighted Average and Diluted) surged by 7777.78% in 2023, and later tumbled by 176153.85% in 2024.
  • bioAffinity Technologies' EPS (Weighted Average and Diluted) (Quarter) stood at $0.22 in 2022, then tumbled by 218.18% to -$0.26 in 2023, then rose by 5.89% to -$0.24 in 2024, then tumbled by 1837.13% to -$4.74 in 2025.
  • Its last three reported values are -$4.74 in Q3 2025, -$0.17 for Q2 2025, and -$0.16 during Q1 2025.